BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:44 PM
 | 
Jan 05, 2009
 |  BC Extra  |  Company News

FDA posts Sabril briefing documents

FDA posted briefing documents ahead of the Jan. 7-8 meeting of FDA's Peripheral and Central Nervous System Drugs Advisory Committee meeting to discuss a pair of NDAs from Ovation (Deerfield, Ill.) for Sabril vigabatrin. The applications for the irreversible inhibitor of GABA-transaminase are for use as an adjunct to treat refractory complex partial seizures in adults and to treat infantile...

Read the full 283 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >